Thyroid C-mobile Tumors: In rodent reports, semaglutide is proven to cause thyroid C-mobile tumors. It truly is unknown whether this risk relates to human beings, but semaglutide is contraindicated in clients with a personal or spouse and children record of medullary thyroid carcinoma (MTC) or clients with Various Endocrine Neoplasia syndrome type